Intra-Cellular Therapies Inc (ITCI)
73.26
+1.13
(+1.57%)
USD |
NASDAQ |
Apr 26, 16:00
73.33
+0.07
(+0.10%)
Pre-Market: 20:00
Intra-Cellular Therapies Price: 73.26 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 26, 2024 | 72.27 | 73.52 | 71.66 | 73.26 | 572959.0 |
| Apr 25, 2024 | 72.46 | 72.78 | 71.35 | 72.13 | 658777.0 |
| Apr 24, 2024 | 73.74 | 74.12 | 72.41 | 73.12 | 736512.0 |
| Apr 23, 2024 | 75.06 | 76.89 | 73.69 | 74.01 | 826601.0 |
| Apr 22, 2024 | 73.68 | 75.14 | 72.02 | 74.54 | 1.928M |
| Apr 19, 2024 | 72.31 | 74.56 | 70.93 | 72.37 | 2.189M |
| Apr 18, 2024 | 74.40 | 75.08 | 71.20 | 72.00 | 4.711M |
| Apr 17, 2024 | 79.00 | 83.25 | 76.50 | 76.69 | 2.862M |
| Apr 16, 2024 | 75.29 | 84.89 | 75.00 | 79.84 | 7.381M |
| Apr 15, 2024 | 65.71 | 66.05 | 64.16 | 64.76 | 503322.0 |
| Apr 12, 2024 | 68.04 | 68.67 | 64.84 | 65.88 | 586929.0 |
| Apr 11, 2024 | 67.89 | 68.68 | 66.53 | 67.97 | 431105.0 |
| Apr 10, 2024 | 67.12 | 68.12 | 66.53 | 67.28 | 541589.0 |
| Apr 09, 2024 | 68.07 | 69.02 | 67.90 | 68.62 | 493243.0 |
| Apr 08, 2024 | 68.74 | 68.90 | 67.32 | 67.70 | 376861.0 |
| Apr 05, 2024 | 67.29 | 69.50 | 67.02 | 68.44 | 702125.0 |
| Apr 04, 2024 | 68.49 | 69.33 | 66.61 | 67.21 | 661496.0 |
| Apr 03, 2024 | 66.28 | 68.73 | 65.99 | 67.32 | 586293.0 |
| Apr 02, 2024 | 66.94 | 67.55 | 65.93 | 66.67 | 502775.0 |
| Apr 01, 2024 | 69.20 | 69.36 | 67.73 | 68.27 | 367886.0 |
| Mar 28, 2024 | 69.78 | 70.00 | 68.14 | 69.20 | 878657.0 |
| Mar 27, 2024 | 67.94 | 69.75 | 67.50 | 69.72 | 428676.0 |
| Mar 26, 2024 | 68.88 | 69.27 | 67.13 | 67.33 | 303687.0 |
| Mar 25, 2024 | 69.59 | 70.07 | 67.82 | 67.97 | 639309.0 |
| Mar 22, 2024 | 68.74 | 69.90 | 68.74 | 69.02 | 821338.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.26
Minimum
Oct 01 2019
79.84
Maximum
Apr 16 2024
39.76
Average
40.87
Median
Nov 16 2021
Price Benchmarks
| Johnson & Johnson | 146.14 |
| Insmed Inc | 24.80 |
| Vertex Pharmaceuticals Inc | 397.48 |
| Fate Therapeutics Inc | 3.80 |
| ADMA Biologics Inc | 6.55 |
Price Related Metrics
| PS Ratio | 15.20 |
| Price to Book Value | 11.99 |
| Earnings Yield | -1.99% |
| Market Cap | 7.092B |